Literature DB >> 12443593

Fever in pregnancy and risk of fetal death: a cohort study.

Anne-Marie Nybo Andersen1, Pernille Vastrup, Jan Wohlfahrt, Per Kragh Andersen, Jørn Olsen, Mads Melbye.   

Abstract

BACKGROUND: Hyperthermia acts as a teratogen in some animals where it can induce resorption of the fetus and fetal death. Fever during pregnancy, especially in the period of embryogenesis, is also suspected as being a risk factor for fetal death in human beings. We did a large cohort study in Denmark to investigate this possibility.
METHODS: We interviewed 24040 women who were recruited in the first half of pregnancy to the Danish National Birth Cohort Study, and obtained information on the number of fever incidents during the first 16 weeks of pregnancy. For each fever episode, the highest measured body temperature, duration of incident, and gestational age were recorded. Outcomes of pregnancies were identified through linkage with the Civil Registration System and the National Discharge Registry. Cox's regression with time-dependent variables was used to estimate the relative risk of fetal death, taking delayed entry into account.
FINDINGS: 1145 pregnancies resulted in a miscarriage or stillbirth (4.8%). During the first 16 pregnancy weeks 18.5% of the women experienced at least one episode of fever. However, we found no association between fever in pregnancy and fetal death before or after adjustment for known risk factors of fetal death (relative risk 0.95 [95% CI 0.80-1.13]). This finding was consistent irrespective of measured maximum temperature, duration and number of fever incidents, or the gestational time of the fever incident, and was observed for fetal death in all three trimesters of pregnancy.
INTERPRETATION: We found no evidence that fever in the first 16 weeks of pregnancy is associated with the risk of fetal death in clinically recognised pregnancies.

Entities:  

Mesh:

Year:  2002        PMID: 12443593     DOI: 10.1016/S0140-6736(02)11518-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.

Authors:  Björn Pasternak; Henrik Svanström; Ditte Mølgaard-Nielsen; Tyra G Krause; Hanne-Dorthe Emborg; Mads Melbye; Anders Hviid
Journal:  BMJ       Date:  2012-05-02

2.  Symptomatic Dengue infection during pregnancy and infant outcomes: a retrospective cohort study.

Authors:  Eleanor E Friedman; Fadi Dallah; Emily W Harville; Leann Myers; Pierre Buekens; Gerard Breart; Gabriel Carles
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

3.  Fever in pregnancy and the risk of congenital malformations: a cohort study.

Authors:  L Sass; S K Urhoj; J Kjærgaard; J W Dreier; K Strandberg-Larsen; A-M Nybo Andersen
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-08       Impact factor: 3.007

4.  The association between seasonal influenza-like illness cases and foetal death: a time series analysis.

Authors:  I S Rasmussen; L H Mortensen; T G Krause; A-M Nybo Andersen
Journal:  Epidemiol Infect       Date:  2018-12-03       Impact factor: 2.451

5.  Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis.

Authors:  Stephanie Antoun; Pierre Ellul; Hugo Peyre; Michelle Rosenzwajg; Pierre Gressens; David Klatzmann; Richard Delorme
Journal:  Mol Autism       Date:  2021-09-18       Impact factor: 7.509

6.  Drinking water nitrate and risk of pregnancy loss: a nationwide cohort study.

Authors:  Ninna Hinchely Ebdrup; Jörg Schullehner; Ulla Breth Knudsen; Zeyan Liew; Anne Marie Ladehoff Thomsen; Julie Lyngsø; Bjørn Bay; Linn Håkonsen Arendt; Pernille Jul Clemmensen; Torben Sigsgaard; Birgitte Hansen; Cecilia Høst Ramlau-Hansen
Journal:  Environ Health       Date:  2022-09-16       Impact factor: 7.123

7.  Maternal use of antibiotics and the risk of childhood febrile seizures: a Danish population-based cohort.

Authors:  Jessica E Miller; Lars Henning Pedersen; Mogens Vestergaard; Jørn Olsen
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.